LLY · Categories · Coverage
LLY - Analyst coverage initiated
Eli Lilly and Company (LLY) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for LLY
- RBC Capital Mkts initiated coverage on Eli Lilly with a new price targetRBC Capital Mkts initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $1,250.00
- Barclays initiated coverage on Eli Lilly with a new price targetBarclays initiated coverage of Eli Lilly with a rating of Overweight and set a new price target of $1,350.00
- Scotiabank initiated coverage on Eli Lilly with a new price targetScotiabank initiated coverage of Eli Lilly with a rating of Sector Outperform and set a new price target of $1,165.00
- Cantor Fitzgerald initiated coverage on Eli Lilly with a new price targetCantor Fitzgerald initiated coverage of Eli Lilly with a rating of Overweight and set a new price target of $975.00
- Wolfe Research initiated coverage on Eli Lilly with a new price targetWolfe Research initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $1,000.00
- Bernstein initiated coverage on Eli Lilly with a new price targetBernstein initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $1,100.00
- Deutsche Bank initiated coverage on Eli Lilly with a new price targetDeutsche Bank initiated coverage of Eli Lilly with a rating of Hold and set a new price target of $535.00
- HSBC Securities initiated coverage on Eli Lilly with a new price targetHSBC Securities initiated coverage of Eli Lilly with a rating of Buy and set a new price target of $560.00
- Jefferies initiated coverage on Eli Lilly with a new price targetJefferies initiated coverage of Eli Lilly with a rating of Hold and set a new price target of $290.00
- Credit Suisse initiated coverage on Eli Lilly with a new price targetCredit Suisse initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $395.00
- SVB Leerink initiated coverage on Eli Lilly with a new price targetSVB Leerink initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $341.00
- Daiwa Securities initiated coverage on Eli Lilly with a new price targetDaiwa Securities initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $286.00
- Goldman initiated coverage on Eli Lilly with a new price targetGoldman initiated coverage of Eli Lilly with a rating of Neutral and set a new price target of $236.00
- BMO Capital initiated coverage on Eli Lilly with a new price targetBMO Capital initiated coverage of Eli Lilly with a rating of Outperform and set a new price target of $311.00